Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127041311 | 12704131 | 1 | I | 201608 | 20160824 | 20160831 | 20160831 | EXP | JP-PFIZER INC-2016403354 | PFIZER | 67.00 | YR | M | Y | 0.00000 | 20160831 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127041311 | 12704131 | 1 | PS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | UNK | U | 11719 | CAPSULE | ||||||||
| 127041311 | 12704131 | 2 | C | INFLIXIMAB | INFLIXIMAB | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127041311 | 12704131 | OT |
| 127041311 | 12704131 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127041311 | 12704131 | Blood beta-D-glucan increased | |
| 127041311 | 12704131 | Dyspnoea | |
| 127041311 | 12704131 | Pneumocystis jirovecii pneumonia | |
| 127041311 | 12704131 | Polymerase chain reaction positive | |
| 127041311 | 12704131 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127041311 | 12704131 | 1 | 201607 | 0 | ||
| 127041311 | 12704131 | 2 | 201607 | 0 |